Big pharmas found guilty of drug collusion in Italy
Novartis and Roche were found to have joined together to push the cost of their drugs higher, and actively worked together to exclude other cheaper drugs.
March 06, 2014 at 04:07 AM
2 minute read
The original version of this story was published on Law.com
Two major Swiss pharmaceutical companies are under fire in Italy after the country's antitrust agency charged them with colluding on the sale of drugs. Novartis and Roche were found to have joined together to push the cost of their drugs higher, and actively worked together to exclude other cheaper drugs.
The two companies collaborated to push their Lucentis medications, which blocks growth of abnormal blood vessels. The treatment addresses age-related macular degeneration by blocking the growth of such blood vessels in the eye.
According to The Wall Street Journal, the Italian Competition Authority found Roche and Novartis in collusion for pushing doctors to purposefully exclude other less expensive drugs that perform similar treatments as Lucentis from the market.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 4'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 5'You Are Not Alone': 120 Sex Assault Victims Plan to Sue Sean 'Diddy' Combs
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250